drugset / Trial / NCT00539890

Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus

NCT00539890

Phase 3 Completed Mannkind Corporation
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare the efficacy of prandial TI plus basal insulin versus prandial rapid acting, subcutaneous insulin plus basal insulin in subjects with type 2 diabetes who had an HbA1c \>7.0% and \<11.5%.

Timeline

Start
2005-11
Primary completion
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Inhaled